Position in DXCM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,557,157
-$345,549 QoQ
Shares Held
52,816
-15.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#314
of 971 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 33%
Shared 1%
None 66%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Focus Partners Wealth holds $351,020,098 across 38 Medical Devices names. DXCM ranks #10 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
1,753,727 | $159,133,187 | |
| 2 | SYK |
Stryker Corp
|
184,736 | $58,162,282 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
813,268 | $52,057,284 | |
| 4 | MDT |
Medtronic plc
|
391,155 | $30,600,055 | |
| 5 | BSX |
Boston Scientific Corp
|
383,366 | $16,362,060 | |
| 6 | ITGR |
Integer Holdings Corp
|
67,575 | $6,314,883 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
66,322 | $5,709,660 | |
| 8 | STE |
STERIS plc
|
22,184 | $4,671,284 |
All Filings in DXCM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,557,157 | 52,816 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,902,706 | 62,145 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,616,501 | 54,490 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,839,574 | 27,338 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,371,843 | 27,172 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $492,917 | 7,218 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $495,939 | 6,377 | Shares | Sole | 2025-05-20 | |
| No filing history on record for this holder in this stock. | ||||||